Related Experiment Video
Updated: Feb 16, 2026

Building Up a High-throughput Screening Platform to Assess the Heterogeneity of HER2 Gene Amplification in Breast Cancers
Published on: December 5, 2017
Immunohistochemical assessment of HER2 protein in breast carcinomas - current status
Abstract:
The existing HER2 immunohistochemistry testing is currently experiencing changes in its scoring caused by the recent clinical trials results, especially DESTINY Breast 04 and 06. These trials demonstrated that any detectable immunohistochemical positivity of HER2 protein on tumor cells is a predictor of response to the new antibody-drug conjugate trastuzumab deruxtecan. These studies introduced new terms "HER2 low" and later "HER2 ultralow" to distinguish subgroups within the original category "HER2 negative", which quickly became accepted in clinical practice. This article aims to explain these new terms and present Czech and international expert recommendations for testing and reporting of HER2 immunohistochemistry in relation to these new categories.
More Related Videos
07:13Initiation of Metastatic Breast Carcinoma by Targeting of the Ductal Epithelium with Adenovirus-Cre: A Novel Transgenic Mouse Model of Breast Cancer
Published on: March 26, 2014
08:16Preparation and Analysis of In Vitro Three Dimensional Breast Carcinoma Surrogates
Published on: May 9, 2016
Related Concept Videos
Marcia's Theory of Identity Status
Electrical Current
Current Density
Eddy Currents
Other major applications of eddy currents appear in metal detectors and the braking systems of trains and roller...
Displacement Current
Charge and Current
Charge is an inherent property of the atomic particles that make up matter and is measured in units called coulombs (C). Matter is composed of atoms, each consisting of electrons, protons, and neutrons. Electrons have a negative charge (-e), while protons...